Client intelligence
What's happening at the client
▍ Phase III oncology trial reads out positive
- Phase III oncology trial reads out positive2026-06-12
- FDA approval expected Q4 for lead asset2026-05-18
Industry trend
Where the market is moving
▍ Life sciences product liability
- Life sciences product liability→ 0% YoYPricing flat as capacity returns
- Clinical trials L&G↑ +18%Asia trial volume +18%
Emerging risks
On the horizon
▍ AI-derived diagnostics liability
- AI-derived diagnostics liabilityMediumNew AI imaging product
- Bio-IP theft via cyberHighRecent peer breach incidents
AI synthesis
Market & risk brief
AI